NeoGenomics Inc (NEO)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 660,566 | 644,118 | 628,248 | 610,663 | 591,643 | 574,796 | 551,624 | 529,779 | 509,728 | 496,755 | 489,313 | 485,965 | 484,329 | 484,594 | 488,698 | 453,951 | 444,448 | 425,319 | 404,547 | 419,283 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $660,566K ÷ $—K
= —
The receivables turnover ratio for NeoGenomics Inc is unavailable for all the indicated periods, from March 31, 2020, to December 31, 2024, according to the provided data. The receivables turnover ratio is a measure of a company's efficiency in managing its receivables, indicating how many times during a period the company collects its average accounts receivable balance.
Without the specific values for the turnover ratio, it is challenging to assess NeoGenomics' effectiveness in collecting outstanding payments from its customers. A higher turnover ratio is generally desirable as it suggests a faster collection of receivables, which can improve cash flow and liquidity. Conversely, a low turnover ratio may signal potential issues with customer creditworthiness or collection processes.
NeoGenomics Inc may need to provide more specific financial data or disclosures to enable a thorough analysis of its receivables turnover and to evaluate its efficiency in managing accounts receivable effectively.